PRL and Parkinson disease: However, some studies have shown that patients with Parkinson’s disease have higher PRL levels, possibly because of the degeneration of dopaminergic neurons in Parkinson’s disease, and trihexyphenidyl, as an oral anticholinergic drug, does not cause an increase in PRL levels (33, 34).